Clinical trial
Intensity Modulated Radiation Therapy - Prostate Cancer
NCT00188513 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188513 |
|---|---|
| Title | Intensity Modulated Radiation Therapy - Prostate Cancer |
| Official title | A Phase I-II Prospective Trial of Conformal Hypofractionated Intensity Modulated Radiotherapy (IMRT) for Localized Adenocarcinoma of the Prostate |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Procedure |
| Interventions | conformal intensity modulated radiotherapy (IMRT) |
| Enrollment | 267 |
| Start date | May 1, 2001 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 4, 2017 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 12, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: